Cargando…
Identification of capsazepine as a novel inhibitor of system x(c)(−) and cancer-induced bone pain
The cystine/glutamate antiporter has been implicated in a variety of cancers as a major mediator of redox homeostasis. The excess glutamate secreted by this transporter in aggressive cancer cells has been associated with cancer-induced bone pain (CIBP) from distal breast cancer metastases. High-thro...
Autores principales: | Fazzari, Jennifer, Balenko, Matthew D, Zacal, Natalie, Singh, Gurmit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402992/ https://www.ncbi.nlm.nih.gov/pubmed/28458574 http://dx.doi.org/10.2147/JPR.S125045 |
Ejemplares similares
-
Effect of glutaminase inhibition on cancer-induced bone pain
por: Fazzari, Jennifer, et al.
Publicado: (2019) -
Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain
por: Fazzari, Jennifer, et al.
Publicado: (2015) -
Rat model of cancer-induced bone pain: changes in nonnociceptive sensory neurons in vivo
por: Zhu, Yong Fang, et al.
Publicado: (2017) -
Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression
por: Nashed, Mina G., et al.
Publicado: (2017) -
Differences in electrophysiological properties of functionally identified nociceptive sensory neurons in an animal model of cancer-induced bone pain
por: Zhu, Yong Fang, et al.
Publicado: (2016)